1. Home
  2. OSIS vs SWTX Comparison

OSIS vs SWTX Comparison

Compare OSIS & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • SWTX
  • Stock Information
  • Founded
  • OSIS 1987
  • SWTX 2017
  • Country
  • OSIS United States
  • SWTX United States
  • Employees
  • OSIS N/A
  • SWTX N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • SWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • SWTX Health Care
  • Exchange
  • OSIS Nasdaq
  • SWTX Nasdaq
  • Market Cap
  • OSIS 3.6B
  • SWTX 3.5B
  • IPO Year
  • OSIS 1997
  • SWTX 2019
  • Fundamental
  • Price
  • OSIS $232.51
  • SWTX N/A
  • Analyst Decision
  • OSIS Strong Buy
  • SWTX Buy
  • Analyst Count
  • OSIS 6
  • SWTX 7
  • Target Price
  • OSIS $228.33
  • SWTX $56.86
  • AVG Volume (30 Days)
  • OSIS 219.8K
  • SWTX 4.5M
  • Earning Date
  • OSIS 08-21-2025
  • SWTX 08-06-2025
  • Dividend Yield
  • OSIS N/A
  • SWTX N/A
  • EPS Growth
  • OSIS 13.25
  • SWTX N/A
  • EPS
  • OSIS 8.23
  • SWTX N/A
  • Revenue
  • OSIS $1,689,088,000.00
  • SWTX $219,670,000.00
  • Revenue This Year
  • OSIS $13.01
  • SWTX $74.36
  • Revenue Next Year
  • OSIS $5.12
  • SWTX $75.63
  • P/E Ratio
  • OSIS $28.21
  • SWTX N/A
  • Revenue Growth
  • OSIS 14.93
  • SWTX 730.42
  • 52 Week Low
  • OSIS $129.18
  • SWTX $28.21
  • 52 Week High
  • OSIS $241.64
  • SWTX $62.00
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 60.06
  • SWTX 63.68
  • Support Level
  • OSIS $210.24
  • SWTX $46.93
  • Resistance Level
  • OSIS $230.46
  • SWTX $47.01
  • Average True Range (ATR)
  • OSIS 7.30
  • SWTX 0.05
  • MACD
  • OSIS 0.53
  • SWTX -0.06
  • Stochastic Oscillator
  • OSIS 87.61
  • SWTX 90.00

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

Share on Social Networks: